DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CADUET

« Back to Dashboard

Clinical Trials for Caduet

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00150384	Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population	Completed	Pfizer	Phase 4	The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population
NCT00332761	Caduet in an Untreated Subject Population	Completed	Pfizer	Phase 4	The purpose of this study is to determine if Caduet will lower blood pressure to <140/90 mmHg and lower LDL Cholesterol to <100 mg/dL in subjects with hypertension and dyslipidemia who are not currently being treated for these medical conditions.
NCT00407537	Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors	Completed	Pfizer	Phase 4	To investigate whether a Caduet based treatment strategy might result in greater reduction in total cardiovascular risk as compared to usual care in subjects with hypertension and additional risk factors.
NCT00412113	A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk	Completed	Pfizer	Phase 4	The purpose of this study is to investigate whether an aggressive multi-risk factor management strategy (Caduet plus therapeutic lifestyle changes (TLC) regimen) will result in greater percentage of patients achieving blood pressure and low density lipoprotein cholesterol (LDL-C) goals compared with a Joint National Committee 7/ National Cholesterol Education Program Adult Treatment Panel III (JNC 7/NCEP ATP III) guideline-based approach (Norvasc plus TLC regimen) after 6 weeks of treatment in primary prevention subjects with hypertension and additional risk factors, including dyslipidemia.
NCT00579254	Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors	Terminated	Pfizer	Phase 4	To assess the effect of single pill therapy on the management of hypertension and other cardiovascular risk factors (e.g., dyslipidemia) in Indian patients in whom the treating doctor has already considered that the administration of the amlodipine/atorvastatin single pill to be appropriate

Clinical Trial Conditions for Caduet

Condition Name

Condition Name for Caduet
Intervention	Trials
Hypertension	6
Hypercholesterolemia	3
Dyslipidemia	3
Angina Pectoris	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Caduet
Intervention	Trials
Dyslipidemias	3
Hypertension	3
Hypercholesterolemia	3
Angina Pectoris	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Caduet

Trials by Country

Trials by Country for Caduet
Location	Trials
United States	66
Japan	8
Mexico	4
Venezuela	3
Korea, Republic of	3

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Caduet
Location	Trials
California	3
Texas	3
Tennessee	3
Pennsylvania	3
Ohio	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Caduet

Clinical Trial Phase

Clinical Trial Phase for Caduet
Clinical Trial Phase	Trials
Phase 4	9
Phase 1	2
N/A	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Caduet
Clinical Trial Phase	Trials
Completed	9
Not yet recruiting	1
Terminated	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Caduet

Sponsor Name

Sponsor Name for Caduet
Sponsor	Trials
Pfizer	8
Dr. Reddy's Laboratories Limited	2
The University of Texas Medical Branch, Galveston	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Caduet
Sponsor	Trials
Industry	10
Other	4

Export unavailable in trial.
Subscribe for complete access.